Analgesics (Pharmacies) - Azerbaijan

  • Azerbaijan
  • Revenue in the Analgesics market is projected to reach US$70.50m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 7.79%, resulting in a market volume of US$102.60m by 2029.
  • In global comparison, most revenue will be generated in China (US$5,028.00m in 2024).
  • In relation to total population figures, per person revenues of US$6.74 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics (Pharmacies) market in Azerbaijan has been experiencing significant growth in recent years.

Customer preferences:
Customers in Azerbaijan have shown a strong preference for analgesics purchased from pharmacies. This preference is driven by several factors. Firstly, customers trust the expertise and advice of pharmacists when it comes to choosing the right analgesic for their needs. Pharmacists are seen as knowledgeable and reliable sources of information, which gives customers confidence in their purchasing decisions. Additionally, customers value the convenience of being able to purchase analgesics alongside other healthcare products in one location. Pharmacies often offer a wide range of analgesics, allowing customers to choose from different brands and formulations based on their individual preferences and needs.

Trends in the market:
One of the key trends in the Analgesics (Pharmacies) market in Azerbaijan is the increasing demand for over-the-counter (OTC) analgesics. OTC analgesics do not require a prescription and can be purchased directly from pharmacies. This trend is driven by several factors. Firstly, customers are becoming more proactive in managing their own health and are seeking self-care options for common ailments such as headaches and muscle pain. OTC analgesics provide a convenient and accessible solution for these customers. Secondly, the rising healthcare costs and limited access to healthcare professionals have also contributed to the growing demand for OTC analgesics. Customers are increasingly turning to pharmacies as a first point of contact for healthcare advice and treatment options, including analgesics.

Local special circumstances:
Azerbaijan has a well-developed healthcare system with a strong emphasis on pharmaceutical care. The government has implemented policies and regulations to ensure the quality and safety of pharmaceutical products, including analgesics. This has created a favorable environment for the growth of the Analgesics (Pharmacies) market in the country. Additionally, the increasing urbanization and changing lifestyles in Azerbaijan have also contributed to the demand for analgesics. Urban areas have seen a rise in sedentary lifestyles and increased stress levels, leading to a higher incidence of conditions such as headaches and muscle pain.

Underlying macroeconomic factors:
The growing economy of Azerbaijan has played a significant role in the development of the Analgesics (Pharmacies) market. As the country's GDP continues to increase, consumers have more disposable income to spend on healthcare products, including analgesics. Furthermore, the government's focus on healthcare and pharmaceutical development has led to increased investment in the sector, creating opportunities for both local and international players in the Analgesics (Pharmacies) market. The overall stability and growth of the economy have also contributed to increased consumer confidence, leading to higher demand for analgesics. In conclusion, the Analgesics (Pharmacies) market in Azerbaijan is experiencing growth due to customer preferences for pharmacy purchases, increasing demand for OTC analgesics, local special circumstances such as a well-developed healthcare system, and underlying macroeconomic factors including a growing economy and increased consumer confidence.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)